ESG | HitGen Releases 2025 Sustainability Report
CHENGDU, China, April 29, 2026 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) released its 2025 Sustainability Report on April 29, 2026. This report is the second sustainability report of HitGen, aiming...
Daqo New Energy Announces Unaudited First Quarter 2026 Financial Results
SHANGHAI, April 29, 2026 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy" the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced its unaudited financial results...
China's Yangtze River Pharmaceutical Group Expands Global Footprint as Quality Drives Growth
TAIZHOU, China, April 29, 2026 /PRNewswire/ -- In 2025, Yangtze River Pharmaceutical Group (YRPG) made significant progress in both global growth and quality initiatives. The company's international revenue increased more than fourfold year over...
STARTRADER Transforms Basketball Court for 10,000 Youth Annually in Vietnam
STARTRADER Completes Basketball Court Upgrade Serving 10,000 Youth Annually The newly upgraded basketball court is now in active use, providing a safe, structured sports environment for daily learning and development. HO CHI MINH CITY, Vietnam,...
GAC Debuts Three Global Models at Auto China 2026 as It Accelerates Global Push
BEIJING, April 29, 2026 /PRNewswire/ -- On April 24, at the Auto China 2026, GAC International held its first dedicated global launch event, unveiling an upgraded global strategy system. The event drew a larger audience than ever before, with...
JinkoSolar Files 2025 Annual Report on Form 20-F
SHANGRAO, China, April 29, 2026 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), a global leader in clean energy technology, today announced that the Company filed its annual report on Form 20-F for the...
European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
SHANGHAI, April 29, 2026 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for...
Cognizant to Acquire Astreya, Deepening Its AI-First Managed Services Capabilities at Scale
Acquisition will expand Cognizant's AI builder technology stack with production-grade AI operations capabilities Astreya, a specialist in AI infrastructure and data center services with deep expertise in data center and managed workplace services,...